文献速递其他结缔组织病

以色列系统性硬化症全国研究:临床特征、民族与空间差异

Systemic sclerosis in Israel clinical characteristics, ethnic and spatial disparities: A nationwide study.
PubMed 文献 · Semin Arthritis Rheum · 2026-09-13

该全国性流行病学与生态学研究纳入以色列1205个地区的3,567,009人及2866例系统性硬化症(SSc)患者,估算患病率、发病率与死亡率并分析民族和地理分布模式。SSc患病率从2000年107/百万升至2023年627/百万,发病率稳定,标化死亡率为2.88,患病率存在显著空间自相关且北部出现聚集,德鲁兹地区患病率持续最高。

要点

  • 以色列SSc患病率由2000年107/百万升至2023年627/百万,居世界较高水平
  • 患病率存在空间聚集,德鲁兹地区患病率最高,校正空间依赖后阿拉伯地区患病率较低

核心结论

  • 以色列SSc患病率属全球报告最高之列,并呈明显空间聚集;考虑空间依赖后民族差异有所变化,德鲁兹地区患病率持续偏高。

研究设计与样本

  • 全国性流行病学与生态学研究,基于Clalit Health Services数据,覆盖1205个地区、3,567,009人及2866例SSc患者。
  • 采用Moran's I与局部空间关联指标(LISA)评估空间自相关,用负二项回归与贝叶斯空间泊松模型分析民族与患病率关联并校正社会经济地位(SES)。

主要发现

  • 患病率呈显著空间自相关(Moran's I = 0.065,p < 0.001),在以色列北部形成聚集。
  • 非空间模型中德鲁兹地区患病率高于犹太地区(PRR 1.45,95%CI 1.04-2.01),阿拉伯地区无差异;空间校正后阿拉伯地区患病率较低(RR 0.78,95%CI 0.64-0.94),德鲁兹地区最高。
  • 较高的社会经济地位与患病率升高相关。

关键数值与推荐

  • 患病率:2000年107/百万,2023年627/百万。
  • 标化死亡率:2.88。
  • Moran's I = 0.065,p < 0.001。
  • 德鲁兹vs犹太地区PRR 1.45(95%CI 1.04-2.01);空间校正后阿拉伯地区RR 0.78(95%CI 0.64-0.94)。

临床怎么用

  • 提示临床关注SSc的地理与民族分布差异,在北部及德鲁兹人群等高风险地区提高筛查与早期识别意识。
  • 关注高社会经济地位人群的患病风险信号,结合空间流行病学信息优化资源配置。

局限性

  • 为流行病学与生态学研究,使用行政健康数据,生态学关联不能推断个体层面因果。
  • 原文未报告研究的具体时间跨度、病例定义与数据完整性等细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Systemic sclerosis (SSc) is an autoimmune disease characterized by immune dysregulation, vasculopathy and fibrosis. Epidemiology, Geographical and ethnic variation of SSc in Israel has not been reported. OBJECTIVES: To estimate SSc prevalence, incidence and mortality in Israel, and to identify ethnic and geographic patterns in disease distribution. METHODS: We conducted a nationwide epidemiologic and ecological study of SSc across Israeli localities using Clalit Health Services data. Prevalent cases and population denominators were analysed. Spatial autocorrelation was assessed using Moran's I and Local Indicators of Spatial Association (LISA). Associations between ethnicity and SSc prevalence were examined using negative binomial regression and Bayesian spatial Poisson models, adjusting for socioeconomic status (SES). RESULTS: The study included 3567,009 individuals from 1205 localities and 2866 SSc patients. Prevalence increased from 107 per million in 2000 to 627 per million in 2023, while incidence remained stable (≈2.8-3. 9 per 100,000/year). The standardized mortality rate was 2.88. SSc prevalence showed significant spatial autocorrelation (Moran's I = 0.065, p < 0.001), with clusters in northern Israel. In non-spatial models, Druze localities had higher prevalence than Jewish localities (PRR 1.45, 95% CI 1.04-2.01), while Arab localities did not differ. After spatial adjustment, Arab localities showed lower prevalence (RR 0.78, 95% CI 0.64-0.94). Druze localities showed the highest prevalence . Higher SES was associated with increased prevalence. CONCLUSIONS: SSc prevalence in Israel is among the highest reported worldwide and shows marked spatial clustering. Ethnic differences vary after accounting for spatial dependence, with consistently high prevalence in Druze localities.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Bieber A, Libes I, Keret S, et al. Systemic sclerosis in Israel clinical characteristics, ethnic and spatial disparities: A nationwide study. Semin Arthritis Rheum. 2026. PMID: 42777526. doi:10.1016/j.semarthrit.2026.153077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。